This article was originally published in The Tan Sheet
Allergies should be treated with newer, non-impairing, second-generation antihistamines rather than with older medications such as Pfizer's Benadryl, according to recommendations developed by a panel of 14 experts and published in the May Journal of Allergy and Clinical Immunology. Many antihistamines used to treat allergic rhinitis "may produce sedation, impairment and reduced quality of life," experts state, noting the condition is "more appropriately managed with the relatively non-impairing second-generation antihistamines" such as loratadine (Schering's Claritin). While "further epidemiologic studies on the effects of antihistamines should be performed," the expert group advises physicians that "second generation antihistamines are preferred for all patients"...
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.